| Ph.D | SRM College of Pharmacy, SRMIST, Chennai, TN | Pharmaceutical Chemistry | 2025 |
| M.Pharm | Jawaharlal Nehru Technological University-Anantapur, AP. | Pharmaceutical Chemistry | 2022 |
| B.Pharm | SKU College of Pharmaceuticals Sciences, Sri Krishnadevaraya University- Anantapur, AP. | Pharmacy | 2019 |
CAMPUS: Department of Pharmaceutical Chemistry,Medicine & Health Sciences, Kattankulathur - Chennai.
EXPERIENCE : 4.5 years years of experience.
RESEARCH INTEREST :Drug design, discovery, lead optimization, computational techniques and synthesis of small molecule heterocycles against Cancer.
COURSES :Organic Chemistry, Medicinal Chemistry, Computational chemistry
Drug design, discovery, lead optimization, computational techniques and synthesis of small molecule heterocycles against Cancer.
Lecturer at Akshaya Institute of Pharmacy, Affiliated to Rajiv Gandhi University, Tumkur, Karnataka. (2021-2022)
Full Time Research Scholar (2022-2025)
Handling computational techniques and experience of QSAR Techniques, Pharmacophore modelling and Molecular Dynamics Simulation.
Chagaleti BK, Toghan A, Zaki ME, Oubella A, Haggam RA. Non-Invasive Breast Cancer Detection: Leveraging the Potential of BN-Doped C60 Heterofullerene for Formaldehyde Sensing Using DFT Theory. Computational Biology and Chemistry. 2025 Sep 18:108692.
Al-Saleem MS, Mukhrish YE, Chagaleti BK, Al-Humaidi JY, Mk K, Oubella A, Haggam RA. Exploration of Novel Pyrazole Derivatives: Design, Synthesis, and Integrated Biological Profiling (In Vitro and In Silico) of Their Antioxidant, Antibacterial, and Antimitotic Properties. Journal of Fluorescence. 2025 Sep 16:1-29.
Irrou E, Ait Elmachkouri Y, El Haddad S, Chagaleti BK, Mague JT, Mk K, Alotaibi SH, Gomha SM, Oubella A, Hassan O, Sebbar NK. Synthesis of novel N4-substituted and C2-disubstituted 1, 4-benzothiazine-1, 1-dioxide derivatives: Integrative computational strategies for breast cancer therapy. Journal of Molecular Structure. 2025 Aug 25;1338:142310.
Chagaleti BK, Saravanan V, Oubella A, Alotaibi SH, Altharawi A, MK K. Pyrazolopyrimidine fused thiazolidinone hybrids as CDK2 inhibitors: insights from pharmacophore modeling, docking, DFT and molecular dynamics simulations. Journal of Molecular Structure. 2025 Aug 5;1336:142009.
Dhivya LS, Chagaleti BK, Saravanan V, Pushparaj S, Manikandan P, Aloyuni S, Al Othaim A, Ismail A, Vijayaraghavan P, Veluchamy A, Arockiaraj J. Anti-Bacterial Activity of Furan Chalcone Derivatives Against Mycobacterium tuberculosis: Design, Synthesis, Anti-Bacterial Screening, Pharmacokinetic Properties, and Toxicity Parameters: Loganathan Sumathi Dhivya et al. Current Microbiology. 2025 Aug;82(8):373.
Sadula A, Chagaleti BK, Enneiymy M, Peddaboina UR, Ankireddy A, Al Ajmi MF, Oubella A. Multifaceted Analysis of Novel Trisubstituted Imidazole Chromen Derivatives: Design, Synthesis, Characterization, Molecular docking, and Antimicrobial Evaluation. Journal of Molecular Structure. 2025 Jul 1:143185.
Krishnu G, Paleti G, Chagaleti BK, Mueen A, Balakrishnan S. Design, Synthesis and Evaluation of Substituted Benzimidazoles as Potent Polyketide Synthase 13 Inhibitors for Tuberculosis. Journal of Young Pharmacists. 2025 Jun 6;17(1):149-59.
Haridevamuthu B, Madesh S, Bharti AK, Kumar A, Dhivya LS, Chagaleti BK, Rajagopal R, Alfarhan A, Kathiravan MK, Arockiaraj J. Therapeutic potential of Thiophene-based Chalcone analog against acrylamide-induced neurotoxicity and Osteotoxicity. Molecular Neurobiology. 2025 May;62(5):5730-43.
Haridevamuthu B, Bharti AK, Nayak SP, Narayanan D, Loganathan Sumathi D, Chagaleti BK, Saravanan V, Rajagopal R, Alfarhan A, Muthu Kumaradoss K, Arockiaraj J. Hydroxyl chalcone derivative DK02 as a multi‐target‐directed ligand for Alzheimer’s disease: A preclinical study in zebrafish. British Journal of Pharmacology. 2025 Apr;182(7):1582-98.
Saravanan V, Palani SP, Chagaleti BK, Gao QZ, Valsaladevi AG, Kumaradoss KM. Molecular dynamics simulation reveals structural insights into isozyme selectivity of carbonic anhydrase XII inhibitors in hypoxic tumor microenvironment. Biochemical and Biophysical Research Communications. 2025 Mar 19;753:151471.
Mukhrish YE, Al-Humaidi JY, Chagaleti BK, Albedair LA, Gomha SM, Saravanan V, Kathiravan MK, Oubella A. Exploring the cyclization of thiosemicarbazone to 1, 3, 4-thiadiazole: synthesis, characterization and in-silico study. Journal of Molecular Structure. 2025 Feb 15;1322:140385.
Laamari Y, Bimoussa A, Chagaleti BK, Saravanan V, Alotaibi SH, Alotaibi FM, MK K, Oubella A, Ait Itto MY, Auhmani A. Thymol-1, 2, 3-triazole derivatives: network pharmacology, molecular simulations and synthesis targeting breast cancer. Journal of Molecular Structure. 2025 Feb 5;1321:140060.
Saravanan V, Kumar CB, Packiapalavesam SD, Muthukumaradoss K. Ligand-Based pharmacophore modelling and quantum computational approaches for the development of hCA XII inhibitor. IEEE Transactions on Computational Biology and Bioinformatics. 2025 Jan 3.
Mantharachalam D, Chagaleti BK, Anjana GV, Shanthakumar B. Exploring natural compound libraries for breast cancer targets: an in silico study. J Nat Remedies. 2025;25(3):639-56.
Laamari Y, Bimoussa A, Mourad F, Chagaleti BK, Saravanan V, Alossaimi MA, Riadi Y, MK K, Oubella A, Ait Itto MY, Auhmani A. Multitargeted molecular docking and dynamics simulation of thymol-based chalcones against cancer protein markers: synthesis, characterization, and computational study. Journal of Molecular Structure. 2024 Dec 5;1317:139116.
Murugan R, Selvam M, Haridevamuthu B, Ashok K, Chagaleti BK, Priya D, Rajagopal R, Alfarhan A, Kumaradoss KM, Arockiaraj J. 1, 5-diaryl pyrazole-loaded chitosan nanoparticles as COX-2 inhibitors, mitigate neoplastic growth by regulating NF-κB pathway in-vivo zebrafish model. International Journal of Biological Macromolecules. 2024 Dec 1;283:137599.
Chagaleti BK, Saravanan V, Kathiravan MK. Discovery of novel CDK2 inhibitors for cancer treatment: integrating ligand-based pharmacophore modelling, molecular docking, DFT, ADMET, and molecular dynamics simulation studies. Beni-Suef University Journal of Basic and Applied Sciences. 2024 Nov 25;13(1):118.
Haridevamuthu B, Nayak SR, Madesh S, Dhivya LS, Chagaleti BK, Pasupuleti M, Rajakrishnan R, Alfarhan A, Kumaradoss KM, Arockiaraj J. A novel brominated chalcone derivative as a promising multi-target inhibitor against multidrug-resistant Listeria monocytogenes. Microbial Pathogenesis. 2024 Nov 1;196:106968.
Chagaleti BK, Baby K, Pena-Corona SI, Leyva-Gomez G, SM S, Naveen NR, Jose J, Aldahish AA, Sharifi-Rad J, Calina D. Anti-cancer properties of Sansalvamide A, its derivatives, and analogs: an updated review. Naunyn-Schmiedeberg’s Archives of Pharmacology. 2024 Oct;397(10):7337-51.
Paleti G, Jena A, Krishnu G, Chagaleti BK, Bhimarao DP, Balakrishnan S. Innovative Thiophene Schiff Bases: Synthesis and Evaluation as Antitubercular Agents. Journal of Young Pharmacists. 2024 Oct 1;16(4).
Chagaleti BK, Anjana GV, Rajagopal R, Alfarhan A, Arockiaraj J, Kumaradoss KM, Namasivayam SK. Targeting cyclin-dependent kinase 2 CDK2: insights from molecular docking and dynamics simulation–a systematic computational approach to discover novel cancer therapeutics. Computational Biology and Chemistry. 2024 Oct 1;112:108134.
Shanthakumar B, Gopinath P, Chagaleti BK, Saravanan V, Palaniappan SK, Almutairi SM, Hussein DS, Eisa YH, Kathiravan MK, Arockiaraj J. Imidazooxazine moiety as polyketide synthase 13 inhibitors targeting tuberculosis. Journal of King Saud University-Science. 2024 Jul 1;36(6):103220.
Thanvi A, Chagaleti BK, Srimathi R, Kathiravan MK, Shanthakumar B. 2, 4-Substituted Oxazolones: Antioxidant Potential Exploration. Journal of Young Pharmacists. 2024 Apr 1;16(2):244.
Saravanan V, Chagaleti BK, Packiapalavesam SD, Kathiravan M. Ligand based pharmacophore modelling and integrated computational approaches in the quest for small molecule inhibitors against hCA IX. RSC advances. 2024;14(5):3346-58.
Chagaleti BK, Reddy MR, Saravanan V, B S, Senthil Kumar P, Kathiravan MK. An overview of mechanism and chemical inhibitors of shikimate kinase. Journal of Biomolecular Structure and Dynamics. 2023 Dec 29;41(23):14582-98.
Saravanan V, Chagaleti BK, Narayanan PL, Anandan VB, Manoharan H, Anjana GV, Peraman R, Namasivayam SK, Kavisri M, Arockiaraj J, Muthu Kumaradoss K. Discovery and development of COVID‐19 vaccine from laboratory to clinic. Chemical Biology & Drug Design. 2024 Jan;103(1):e14383.
Babu NR, Sahoo BM, Radhika T, C BK, Malothu N. Synthesis, Antitubercular Evaluation, Molecular Docking Study, and Teratogenicity Studies of Novel Triazolo Quinazoline Hybrids. Russian Journal of General Chemistry. 2023 Oct;93(10):2684-93.
Jahan J, Barik S, Chagaleti BK, Kathiravan MK, Deivasigamani P. The synthetic approach of benzimidazole derivatives as anti-inflammatory agents. inflammation. 2023;14(19):10-55522.
Chagaleti BK, Saravanan V, Vellapandian C, Kathiravan MK. Exploring cyclin-dependent kinase inhibitors: a comprehensive study in search of CDK-6 inhibitors using a pharmacophore modelling and dynamics approach. RSC advances. 2023;13(48):33770-85.
Shanthakumar B, Saravanan V, Chagaleti BK, Kathiravan MK. Design synthesis and biological evaluation of thiophene 2-pentafluoro benzamide derivatives as antitubercular agent. J Med Pharm Allied Sci. 2023;12(1):5604-12.
Jena A, Prakashraj C, Chagaleti BK, Kathiravan MK, Kumar BS. In silico design and synthesis of some new imidazole derivatives for tuberculosis. Indian J Heterocycl Chem. 2023 Jan 1;33(1):43-9.